Evidence map›Paper›PMID 23746379›Full record

Observational studyAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2013

Correlation of pre-existing vascular pathology with arteriovenous graft outcomes in hemodialysis patients.

Michael Allon, Silvio Litovsky, Carlton J Young, Mark H Deierhoi, Jeremy Goodman, Michael Hanaway, Mark E Lockhart, Michelle L Robbin

Abstract readObservational Study
In one paragraph

Observational study in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Observational
  7. Review
  8. Review
  9. Article
  10. Histopathology of Veins Obtained at Hemodialysis Arteriovenous Fistula Creation Surgery.Journal of the American Society of Nephrology : JASN · 2017
    Article
  11. Review
  12. Article
  13. Preoperative graft assessment in aortocoronary bypass surgery.Experimental and therapeutic medicine · 2016
    Article
  14. Article
  15. c-Kit signaling determines neointimal hyperplasia in arteriovenous fistulae.American journal of physiology. Renal physiology · 2014
    Article
  16. Article
  17. Novel paradigms for dialysis vascular access: Introduction.Clinical journal of the American Society of Nephrology : CJASN · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michael AllonDivision of Nephrology, University of Alabama at Birmingham, Birmingham, AL. Electronic address: mdallon@uab.edu.
Silvio Litovsky
Carlton J Young
Mark H Deierhoi
Jeremy Goodman
Michael Hanaway
Mark E Lockhart
Michelle L Robbin

Funding

University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kirk Michael Habegger · 2013 to 2026
$19.5M
Vascular abnormalities in patients receiving a dialysis access.R01DK085027 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ALLON, MICHAEL · 2010 to 2013
$1.5M
NIDDK NIH HHS P30 DK079626NIDDK NIH HHS R01 DK085027NIDDK NIH HHS R01-DK-085027
6 · The paper itself

Abstract

backgroundArteriovenous grafts (AVGs) are prone to neointimal hyperplasia leading to AVG failure. We hypothesized that pre-existing pathologic abnormalities of the vessels used to create AVGs (including venous intimal hyperplasia, arterial intimal hyperplasia, arterial medial fibrosis, and arterial calcification) are associated with inferior AVG survival. STUDY

designProspective observational study. SETTING &

participantsPatients with chronic kidney disease undergoing placement of a new AVG at a large medical center who had vascular specimens obtained at the time of surgery (n = 76). PREDICTOR: Maximal intimal thickness of the arterial and venous intima, arterial medial fibrosis, and arterial medial calcification. OUTCOME & MEASUREMENTS: Unassisted primary AVG survival (time to first intervention) and frequency of AVG interventions.

results55 patients (72%) underwent interventions and 148 graft interventions occurred during 89.9 years of follow-up (1.65 interventions per graft-year). Unassisted primary AVG survival was not associated significantly with arterial intimal thickness (HR, 0.72; 95% CI, 0.40-1.27; P = 0.3), venous intimal thickness (HR, 0.64; 95% CI, 0.37-1.10; P = 0.1), severe arterial medial fibrosis (HR, 0.58; 95% CI, 0.32-1.06; P = 0.6), or severe arterial calcification (HR, 0.68; 95% CI, 0.37-1.31; P = 0.3). The frequency of AVG interventions per year was associated inversely with arterial intimal thickness (relative risk [RR], 1.99; 95% CI, 1.16-3.42; P < 0.001 for thickness <10 vs. >25 μm), venous intimal thickness (RR, 2.11; 95% CI, 1.39-3.20; P < 0.001 for thickness <5 vs. >10 μm), arterial medial fibrosis (RR, 3.17; 95% CI, 1.96-5.13; P < 0.001 for fibrosis <70% vs. ≥70%), and arterial calcification (RR, 2.12; 95% CI, 1.31-3.43; P = 0.001 for <10% vs. ≥10% calcification). LIMITATIONS: Single-center study. Study may be underpowered to demonstrate differences in unassisted primary AVG survival.

conclusionsPre-existing vascular pathologic abnormalities in patients with chronic kidney disease may not be associated significantly with unassisted primary AVG survival. However, vascular intimal hyperplasia, arterial medial fibrosis, and arterial calcification may be associated with a decreased frequency of AVG interventions.

Indexed as

Arteriovenous Shunt, SurgicalRenal DialysisArmCalcinosisFemaleFibrosisFollow-Up StudiesGraft SurvivalHumansMaleMiddle AgedNeointimaPostoperative ComplicationsProspective StudiesRisk FactorsThighArteriovenous graftintimal hyperplasiamedial fibrosisvascular calcification

Identifiers

PMID23746379
PMCPMC3778052

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.